Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics
Quest Diagnostics, a provider of diagnostic information services, has acquired ConVerge Diagnostic Services, a full-service laboratory providing clinical, cytology and anatomic pathology testing services to patients, physicians and ...
Diagnostic information services provider Quest Diagnostics has rolled out its new lab-developed genetic test to support the delivery of modified opioid pain-relieving treatment. It effectively tests for variants in all cytochrome P450 ...
Quest Diagnostics has acquired the toxicology and clinical laboratory business of medical center operator Concentra. Concentra's Advanced Toxicology Network (ATN) laboratory business operates from a laboratory in Memphis, Tennessee, US. ...
Tags: Quest, Clinical Laboratory Assets
Quest Diagnostics, a provider of diagnostic information services, introduced new blood tests, designed for the early diagnosis of rheumatoid arthritis (RA). The company claimed that RA is an autoimmune disorder and can cause debilitating ...
Tags: blood tests, Medicine
Danish healthcare company Radiometer Medical has purchased Quest Diagnostics' HemoCue diagnostic products business for $300m plus customary adjustments for cash balances. Quest will use the proceeds to repurchase approximately $300m of ...
Diagnostic information services provider Quest Diagnostics has purchased UMass Memorial Medical Center's clinical outreach laboratory and anatomic pathology outreach laboratory businesses based in Worcester, Massachusetts, US. The ...